PaperImmunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use
References (62)
- et al.
Immune response to influenza vaccination of elderly people: a randomized double-blind placebo-controlled trial
Vaccine
(1994) - et al.
Development of a new type of influenza subunit vaccine made by muramyldipeptide-liposome: enhancement of humoral and cellular immune responses
Vaccine
(1990) - et al.
Adhesion-mediated enhancement of the adjuvant activity of alum
Vaccine
(1993) - et al.
A comparative study of the reactogenicity and immunogenicity of two inactivated influenza vaccines in children
J. Biol. Stand.
(1982) - et al.
Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM-matrix
Vaccine
(1995) - et al.
Quaternary structure of the immunostimulating complex (iscom)
J. Ultrastruct. Mol. Struct. Res.
(1989) - et al.
Experimental polyvalent ISCOMs subunit vaccine induces antibodies that neutralize human and bovine respiratory syncytial virus
Vaccine
(1989) - et al.
Initiation of cytotoxic T-cell response and protection of mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine
Vaccine
(1992) - et al.
The iscom structure as an immune-enhancing moiety: experience with viral systems
Res. Immunol.
(1992) - et al.
Influenza virus ISCOMs: antibody response in animals
Vaccine
(1988)
Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier
J. Immunol. Methods
(1987)
Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity
Vaccine
(1987)
Stable oil-in-water emulsions: preparation and use as vaccine vehicles for lipophilic adjuvants
Vaccine
(1985)
Antigenic determinants of influenza virus hemagglutinin. XII. The epitopes of a synthetic peptide representing the C-terminus of HA1
Virology
(1986)
A solid-phase immunoenzymatic technique for the enumeration of specific antibody secreting cells
J. Immunol. Methods
(1983)
Immunoglobulin G: functional sites
Mol. Immunol.
(1985)
Failure of influenza vaccination in the aged
J. Med. Virol.
(1988)
Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization
Ann. Intern. Med.
(1994)
The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community
N. Engl. J. Med.
(1994)
The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature
Ann. Intern. Med.
(1995)
Inactivated influenza virus vaccine
IgG subclass response and protection against challenge following immunization of mice with various influenza A vaccines
J. Med. Microbiol.
(1994)
Lack of adjuvant effect of AIPO4 on purified influenza virus haemaglutinins in man
J. Immunol.
(1968)
Analysing the T cell response to influenza viruses in mouse model systems
Cytotoxic T-cell immunity to influenza
N. Engl. J. Med.
(1983)
The requirement of lipids for the formation of immunostimulating complexes (iscoms)
Biotechnol. Appl. Biochem.
(1988)
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses
Nature
(1984)
An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration
Clin. Exp. Immunol.
(1990)
The IgA and subclass IgG responses and protection in mice immunized with influenza antigens administered as ISCOMS, with FCA ALH or as infectious virus
Arch. Virol.
(1992)
Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice
J. Gen. Virol.
(1988)
Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes
J. Gen. Virol.
(1988)
Cited by (0)
Copyright © 1998 Published by Elsevier Ltd.